Hersh Shroff, MD, MPA

home / authors / hersh-shroff-md

Hersh Shroff, MD, MPA, is a transplant hepatologist and an assistant professor of medicine at the University of North Carolina School of Medicine

Articles

Thumbnail featuring Jay Luther, MD, Hersh Shroff, MD, MPA, and Chris Kahler, PhD

Addressing Stigma to Improve Outcomes in Alcohol-Related Liver Disease

Hersh Shroff, MD, MPA;Jay Luther, MD;Chris Kahler, PhD;Chelsie Derman
April 30th 2024

The second segment of a special report stresses the importance of cross-specialty collaboration with hepatology and psychiatry when treating alcohol-related liver disease.

Read More

Thumbnail featuring Jay Luther, MD, Hersh Shroff, MD, MPA, and Chris Kahler, PhD

Recognizing Stigma's Impact on Care for Alcohol-Related Liver Disease

Hersh Shroff, MD, MPA;Jay Luther, MD;Chris Kahler, PhD;Abigail Brooks, MA
April 30th 2024

In the first segment of this HCPLive special report, experts discuss the stigma surrounding alcohol use disorder and alcohol-associated liver disease.

Read More

Latest Updated Articles

Gursimran Kochhar, MD | Credit: Allegheny Health Network
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
HCPLive Cardiology Month in Review: April 2024
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Published: November 16th 2024 | Updated: December 31st 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Published: November 15th 2024 | Updated: December 31st 2024
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Scott Bartley, MD I Credit: LinkedIn
Published: December 16th 2024 | Updated: December 31st 2024
Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
Published: December 16th 2024 | Updated: December 31st 2024
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
© 2024 MJH Life Sciences

All rights reserved.